Minister of Health’s Decision that JAMP is not a “Second Person” Was Reasonable
In its new drug submission for SIMLANDI, a biosimilar containing adalimumab, JAMP Pharma Corporation (“JAMP”) sought approval for three specific presentations: (i) 40 mg/0.4 mL pre-filled syringe; (ii) 40 mg/0.4 mL auto-injector pen; and (iii) 80 mg/0.8 mL pre-filled syringe.
Given that AbbVie did not market the equivalent presentations of HUMIRA (adalimumab) in Canada, in a comprehensive and detailed decision, the Minister of Health (the “Minister”) determined that JAMP was not a “second person” for purposes of subsection 5(1) of the Patented Medicines (Notice of Compliance) Regulations (the “PM(NOC) Regulations”) and was thus not required to address patents listed on the patent register by AbbVie before being issued a Notice of Compliance (“NOC”).
Subsequently, the Minister issued an NOC to JAMP for its three presentations of SIMLANDI.
In AbbVie Corporation et al. v. The Minister of Health and JAMP Pharma Corporation, 2022 FC 1209, Justice Fothergill of the Federal Court dismissed AbbVie’s applications to judicially review the Minister’s decisions, on the basis that the Minister’s decisions were reasonable.
Justice Fothergill observed that the “PM(NOC) Regulations are closely connected with the Minister’s functions, and the Minister has great expertise in their application and interpretation”.
In summary, Justice Fothergill determined that the “Minister’s interpretation of s 5(1) of the PM(NOC) Regulations as applying only to a version of a drug that has a specific drug identification number [DIN] and that is marketed in Canada was reasonable, particularly considering the statutory objective of providing a patent enforcement mechanism only in relation to products that are in fact available to Canadians”.
Authors
Expertise
Insights
-
Intellectual Property
From Touchdowns to Trademarks: How NFL Star Travis Kelce is Growing his Brand
Travis Kelce, three-time Super Bowl champion and Kansas City Chiefs superstar tight-end, has reportedly filed multiple new trademark applications in Ohio according to records from the United States… -
Intellectual Property
A Bump in the Road: Caterpillar Ordered to Pay Wirtgen $12.9 Million in Patent Trial
The federal jury of a U.S. District Court in Delaware reportedly awarded Wirtgen America Inc. (“Wirtgen”) $12.9 million in damages for patent infringement related to road-construction technology.The… -
Intellectual Property
A Billion-Dollar Remix: U.S. Appeal Court Overturns $1 Billion Copyright Verdict
A U.S. appeal court reportedly found in favour of American telecommunications and internet service provider, Cox Communications (“Cox”), overturning a $1 billion jury verdict awarded to several record… -
Intellectual Property
From Foam to Fortune: Crocs Inc. Prevails in Patent Infringement Case
Crocs Inc. has been awarded over $6 million following a decision regarding patent infringement by USA Dawgs and its subsidiary Double Diamond Distribution. Crocs was embroiled in years of litigation… -
Intellectual Property
Dish and iFit Reach the Finish Line Settling Infringement Dispute
Dish Network and iFit have reportedly reached an agreement to settle their legal disputes over the use of Dish Network’s streaming-video technology in iFit’s exercise equipment. The dispute arose… -
Intellectual Property
General Motors Files Patent Application for Foldable Ramp for Pickup Trucks
General Motors (“GM”) has reportedly filed a patent application with the United States Patent and Trademark Office for a foldable ramp designed for pickup trucks.The foldable ramp is designed to…